BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 928 filers reported holding BAXTER INTL INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $863,392 | +7.0% | 20,202 | -3.2% | 0.02% | -10.7% |
Q4 2023 | $806,641 | -2.8% | 20,865 | -5.1% | 0.03% | -12.5% |
Q3 2023 | $829,940 | -29.6% | 21,991 | -15.0% | 0.03% | -23.8% |
Q2 2023 | $1,179,320 | +10.1% | 25,885 | -2.0% | 0.04% | +2.4% |
Q1 2023 | $1,070,824 | -36.4% | 26,401 | -20.0% | 0.04% | -38.8% |
Q4 2022 | $1,682,926 | -9.8% | 33,018 | -4.7% | 0.07% | -16.2% |
Q3 2022 | $1,866,571 | -16.1% | 34,656 | 0.0% | 0.08% | -10.1% |
Q2 2022 | $2,225,954 | +82068.8% | 34,656 | -0.8% | 0.09% | 0.0% |
Q1 2022 | $2,709 | -99.9% | 34,938 | -1.6% | 0.09% | -4.3% |
Q4 2021 | $3,046,000 | +4.9% | 35,489 | -1.7% | 0.09% | -5.1% |
Q3 2021 | $2,905,000 | -1.9% | 36,119 | -1.8% | 0.10% | -2.0% |
Q2 2021 | $2,961,000 | -5.6% | 36,777 | -1.1% | 0.10% | -11.5% |
Q1 2021 | $3,137,000 | -2.5% | 37,196 | -7.2% | 0.11% | -6.6% |
Q4 2020 | $3,217,000 | -1.0% | 40,089 | -0.8% | 0.12% | -10.4% |
Q3 2020 | $3,251,000 | -6.6% | 40,424 | -0.0% | 0.14% | -16.1% |
Q2 2020 | $3,481,000 | +3.0% | 40,425 | -2.8% | 0.16% | -13.4% |
Q1 2020 | $3,378,000 | -3.2% | 41,609 | -0.2% | 0.19% | +25.7% |
Q4 2019 | $3,488,000 | -7.5% | 41,709 | -3.2% | 0.15% | -14.5% |
Q3 2019 | $3,769,000 | +6.4% | 43,084 | -0.4% | 0.17% | +6.1% |
Q2 2019 | $3,542,000 | -1.7% | 43,252 | -2.4% | 0.16% | -3.6% |
Q1 2019 | $3,604,000 | +15.1% | 44,332 | -6.9% | 0.17% | +1.2% |
Q4 2018 | $3,132,000 | -14.7% | 47,593 | -0.1% | 0.17% | 0.0% |
Q3 2018 | $3,672,000 | +5.0% | 47,644 | +0.6% | 0.17% | -3.5% |
Q2 2018 | $3,496,000 | +10.0% | 47,353 | -3.1% | 0.17% | +9.5% |
Q1 2018 | $3,179,000 | -4.0% | 48,878 | -4.7% | 0.16% | +1.9% |
Q4 2017 | $3,313,000 | +5.5% | 51,268 | +2.4% | 0.16% | +0.6% |
Q3 2017 | $3,141,000 | -1.0% | 50,063 | -4.5% | 0.15% | -2.5% |
Q2 2017 | $3,173,000 | +17.2% | 52,413 | +0.3% | 0.16% | +13.7% |
Q1 2017 | $2,708,000 | +17.2% | 52,232 | +0.2% | 0.14% | +12.1% |
Q4 2016 | $2,311,000 | -9.0% | 52,136 | -2.3% | 0.12% | -8.1% |
Q3 2016 | $2,540,000 | +3.5% | 53,373 | -1.6% | 0.14% | +0.7% |
Q2 2016 | $2,453,000 | +5.6% | 54,264 | -4.1% | 0.13% | +5.5% |
Q1 2016 | $2,324,000 | -2.9% | 56,592 | -9.8% | 0.13% | -3.1% |
Q4 2015 | $2,394,000 | +9.3% | 62,765 | -5.9% | 0.13% | +5.6% |
Q3 2015 | $2,191,000 | -55.0% | 66,707 | -4.2% | 0.12% | -50.4% |
Q2 2015 | $4,867,000 | -12.9% | 69,607 | -14.7% | 0.25% | -9.4% |
Q1 2015 | $5,590,000 | -8.7% | 81,607 | -2.3% | 0.28% | -9.5% |
Q4 2014 | $6,120,000 | +1.6% | 83,515 | -0.5% | 0.30% | -1.9% |
Q3 2014 | $6,022,000 | -1.1% | 83,915 | -0.4% | 0.31% | +1.3% |
Q2 2014 | $6,090,000 | -9.9% | 84,240 | -8.3% | 0.31% | -10.5% |
Q1 2014 | $6,761,000 | -10.6% | 91,899 | -15.5% | 0.34% | -10.2% |
Q4 2013 | $7,563,000 | -1.3% | 108,750 | -6.8% | 0.38% | -12.0% |
Q3 2013 | $7,662,000 | -7.6% | 116,643 | -2.5% | 0.43% | -12.9% |
Q2 2013 | $8,291,000 | – | 119,693 | – | 0.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |